Verastem (VSTM) Revenue (QoQ) (2018 - 2026)
Verastem (VSTM) Revenue (QoQ) (2018 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Verastem |
407.42 Mn |
225.74 Mn |
15.90 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
6.48% |
| Dec 31, 2025 |
55.98% |
| Sep 30, 2025 |
426.06% |
| Mar 31, 2022 |
376.33% |
| Dec 31, 2021 |
27,150.00% |
| Sep 30, 2021 |
-99.60% |
| Jun 30, 2021 |
-50.30% |
| Mar 31, 2021 |
98.81% |
| Dec 31, 2020 |
-99.36% |
| Sep 30, 2020 |
1,726.03% |
| Jun 30, 2020 |
-14.81% |
| Mar 31, 2020 |
39.78% |
| Dec 31, 2019 |
-59.95% |
| Sep 30, 2019 |
188.01% |
| Jun 30, 2019 |
87.67% |
| Mar 31, 2019 |
38.10% |
| Dec 31, 2018 |
-92.20% |
| Sep 30, 2018 |
55.08% |
